
Evan Scott
Bio:
Renowned for his pioneering work utilizing nanotechnology to combat cancer, glaucoma, and heart disease, among other diseases and ailments, Evan Scott leads UVA’s Institute for Nanoscale Scientific and Technological Advanced Research, or nanoSTAR.
Scott brings to UVA more than a decade of experience teaching and spearheading groundbreaking research at Northwestern University. His work, which has been generously funded by the National Institutes of Health, applies principles from biomaterials science, nanotechnology, and tissue engineering towards the development of translational immunotherapies. At UVA, he holds dual appointments in both the School of Medicine and the School of Engineering and Applied Science. In addition, he supports UVA’s Cancer Center and works to foster interdisciplinary collaborations across Grounds.